口腔医学研究 ›› 2019, Vol. 35 ›› Issue (3): 208-211.DOI: 10.13701/j.cnki.kqyxyj.2019.03.002

• 综述 • 上一篇    下一篇

口腔中糖尿病骨病及药物防治的研究进展

苏振宇1, 张斌1,2*   

  1. 1. 哈尔滨医科大学附属第二医院口腔颌面外科 黑龙江 哈尔滨 150001;
    2. 黑龙江省医学科学院 黑龙江 哈尔滨 150001
  • 收稿日期:2018-05-24 出版日期:2019-03-28 发布日期:2019-04-01
  • 通讯作者: * 张斌,E-mail:zhangbin@hrbmu.edu.cn
  • 作者简介:苏振宇(1992~ ),男,山东烟台人,硕士在读,主要从事口腔颌面外科临床工作。
  • 基金资助:
    国家自然科学基金面上项目(编号:81570951)

Research Progress in Oral Diabetic Osteopathy and Drug Control

SU Zhen-yu1, ZHANG Bin1,2*   

  1. 1. Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China;
    2. Heilongjiang Academy of Medical Sciences, Harbin 150001, China.
  • Received:2018-05-24 Online:2019-03-28 Published:2019-04-01

摘要: 糖尿病骨病是一种危害极大的糖尿病并发症,其发病率呈逐年上升趋势。糖尿病导致的慢性高血糖会增加全身骨质疏松及骨折的发生风险。在口腔中可表现为牙周炎、牙槽骨丧失及种植体骨结合失败等,目前其发病机制尚未完全明确。对口腔中糖尿病骨病的研究更多集中于药物治疗的选择。而在实际临床应用中,应该根据药物的不良反应和疾病的严重程度选择合适的药物,确定适当的给药剂量和疗程,最终使患者获得最佳的治疗效果。

关键词: 糖尿病骨病, 口腔, 药物防治

Abstract: Diabetic bone disease is a devastating complication of diabetes, and its incidence rate has been increased year by year. Chronic hyperglycemia caused by diabetes can increase the risk of systemic osteoporosis and fractures. In the oral cavity, it can manifest as periodontitis, loss of alveolar bone, and implant bone failure. At present, its pathogenesis is not completely clear. The study of oral diabetic bone disease focuses more on the choice of drug therapy. In the actual clinical application, drugs should be selected according to the adverse reactions of the drugs and the severity of the disease, and the appropriate dose and treatment course should be determined so that the patient can obtain the best therapeutic effect.

Key words: Diabetic bone disease, Oral, Drug control